Sagent Pharmaceuticals, Inc. - FORM S-1MEF - EX-23.1 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - April 19, 2011

Attached files

file filename
S-1MEF - S-1MEF - Sagent Pharmaceuticals, Inc.ds1mef.htm
EX-5.1 - OPINION OF KIRKLAND & ELLIS LLP - Sagent Pharmaceuticals, Inc.dex51.htm
EX-23.2 - CONSENT OF ERNST & YOUNG HUA MING, INDEPENDENT AUDITORS - Sagent Pharmaceuticals, Inc.dex232.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in this Registration Statement on Form S-1 of our reports dated March 17, 2011, with respect to the consolidated financial statements and schedule of Sagent Holding Co. included in Amendment No. 5 of its Registration Statement (Form S-1 No. 333-170979), filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

Chicago, Illinois

April 19, 2011

Sagent Pharmaceuticals, Inc. Reports